Verrica Pharmaceuticals (VRCA) PT Raised to $12 at Jefferies
Jefferies analyst Glen Santangelo raised the price target on Verrica Pharmaceuticals (NASDAQ: VRCA) to $12.00 (from $10.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)